Literature DB >> 18505811

Temporal and spatial distribution of Toxoplasma gondii differentiation into Bradyzoites and tissue cyst formation in vivo.

Manlio Di Cristina1, Daniela Marocco, Roberto Galizi, Carla Proietti, Roberta Spaccapelo, Andrea Crisanti.   

Abstract

During Toxoplasma gondii infection, a fraction of the multiplying parasites, the tachyzoites, converts into bradyzoites, a dormant stage, which form tissue cysts localized mainly in brain, heart, and skeletal muscles that persist for several years after infection. At this stage the parasite is protected from the immune system, and it is believed to be inaccessible to drugs. While the long persistence of tissue cysts does not represent a medical problem for healthy individuals, this condition represents a major risk for patients with a compromised immune system, who can develop recrudescent life-threatening T. gondii infections. We have investigated for the first time the dynamics and the kinetics of tachyzoite-to-bradyzoite interconversion and cyst formation in vivo by using stage-specific bioluminescent parasites in a mouse model. Our findings provide a new framework for understanding the process of bradyzoite differentiation in vivo. We have also demonstrated that complex molecules such as d-luciferin have access to tissue cysts and are metabolically processed, thus providing a rationale for developing drugs that attack the parasite at this developmental stage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505811      PMCID: PMC2493213          DOI: 10.1128/IAI.00254-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

Review 1.  The development and biology of bradyzoites of Toxoplasma gondii.

Authors:  L M Weiss; K Kim
Journal:  Front Biosci       Date:  2000-04-01

2.  Cerebral toxoplasmosis after combined liver-pancreas-kidney and liver-pancreas transplantation.

Authors:  M Hommann; U Schotte; R Voigt; H Glutig; T Grube; B Küpper; A Kornberg; K Richter; J Scheele
Journal:  Transplant Proc       Date:  2002-09       Impact factor: 1.066

3.  Cerebral toxoplasmosis after autologous peripheral blood stem cell transplantation.

Authors:  M López-Duarte; A Insunza; E Conde; A Iriondo; F Mazorra; A Zubizarreta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-08-27       Impact factor: 3.267

4.  Optical imaging of Renilla luciferase reporter gene expression in living mice.

Authors:  S Bhaumik; S S Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

5.  Toxoplasma gondii: in vivo expression of BAG-5 and cyst formation is independent of TNF p55 receptor and inducible nitric oxide synthase functions.

Authors:  Neide M Silva; Wagner L Tafuri; Jacqueline I Alvarez-Leite; José R Mineo; Ricardo T Gazzinelli
Journal:  Microbes Infect       Date:  2002-03       Impact factor: 2.700

6.  Toxoplasmic pneumonitis leading to fatal acute respiratory distress syndrome after engraftment in three bone marrow transplant recipients.

Authors:  N Ortonne; P Ribaud; V Meignin; C Sarfati; H Esperou; A Devergie; E Gluckman; G Socie; A Janin
Journal:  Transplantation       Date:  2001-12-15       Impact factor: 4.939

Review 7.  Toxoplasma gondii tachyzoite-bradyzoite interconversion.

Authors:  Russell E Lyons; Rima McLeod; Craig W Roberts
Journal:  Trends Parasitol       Date:  2002-05

8.  Immunosuppression and toxoplasmic encephalitis: clinical and experimental aspects.

Authors:  J K Frenkel; B M Nelson; J Arias-Stella
Journal:  Hum Pathol       Date:  1975-01       Impact factor: 3.466

9.  Toxoplasma gondii pneumonia in liver transplantation: survival after a severe case of reactivation.

Authors:  Laura A Barcán; M L Dallurzo; L O Clara; A Valledor; S Macías; E Zorkin; S Gerona; B Livellara
Journal:  Transpl Infect Dis       Date:  2002-06       Impact factor: 2.228

10.  Localized recrudescence of Toxoplasma infections in the central nervous system of immunocompromised mice assessed by in vivo bioluminescence imaging.

Authors:  Isabel Dellacasa-Lindberg; Niclas Hitziger; Antonio Barragan
Journal:  Microbes Infect       Date:  2007-06-10       Impact factor: 2.700

View more
  40 in total

Review 1.  Noninvasive biophotonic imaging for studies of infectious disease.

Authors:  Nuria Andreu; Andrea Zelmer; Siouxsie Wiles
Journal:  FEMS Microbiol Rev       Date:  2010-10-19       Impact factor: 16.408

2.  IL-1R Regulates Disease Tolerance and Cachexia in Toxoplasma gondii Infection.

Authors:  Stephanie J Melchor; Claire M Saunders; Imani Sanders; Jessica A Hatter; Kari A Byrnes; Sheryl Coutermarsh-Ott; Sarah E Ewald
Journal:  J Immunol       Date:  2020-04-29       Impact factor: 5.422

3.  Reexamining Chronic Toxoplasma gondii Infection: Surprising Activity for a "Dormant" Parasite.

Authors:  Anthony P Sinai; Elizabeth A Watts; Animesh Dhara; Robert D Murphy; Matthew S Gentry; Abhijit Patwardhan
Journal:  Curr Clin Microbiol Rep       Date:  2016-10-04

4.  The common parasite Toxoplasma gondii induces prostatic inflammation and microglandular hyperplasia in a mouse model.

Authors:  Darrelle L Colinot; Tamila Garbuz; Maarten C Bosland; Liang Wang; Susan E Rice; William J Sullivan; Gustavo Arrizabalaga; Travis J Jerde
Journal:  Prostate       Date:  2017-05-12       Impact factor: 4.104

5.  Development of dual fluorescent stage specific reporter strain of Toxoplasma gondii to follow tachyzoite and bradyzoite development in vitro and in vivo.

Authors:  T C Paredes-Santos; T Tomita; M Yan Fen; W de Souza; M Attias; R C Vommaro; L M Weiss
Journal:  Microbes Infect       Date:  2015-09-30       Impact factor: 2.700

6.  Targeted disruption of Toxoplasma gondii serine protease inhibitor 1 increases bradyzoite cyst formation in vitro and parasite tissue burden in mice.

Authors:  Viviana Pszenny; Paul H Davis; Xing W Zhou; Christopher A Hunter; Vern B Carruthers; David S Roos
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

Review 7.  Cell type- and species-specific host responses to Toxoplasma gondii and its near relatives.

Authors:  Zhee S Wong; Sarah L Sokol Borrelli; Carolyn C Coyne; Jon P Boyle
Journal:  Int J Parasitol       Date:  2020-05-11       Impact factor: 3.981

8.  In vitro therapeutic effect of Hemiscorpius lepturus venom on tachyzoites of Toxoplasma gondii.

Authors:  L Khaleghi Rostamkolaie; H Hamidinejat; M H Razi Jalali; H Jafari; H Najafzadeh Varzi; M R Seifi Abadshapouri
Journal:  J Parasit Dis       Date:  2019-04-20

Review 9.  Toxoplasma gondii infection and behaviour - location, location, location?

Authors:  Glenn A McConkey; Heather L Martin; Greg C Bristow; Joanne P Webster
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

10.  Indication of Risk of Mother-to-Child Toxoplasma gondii Transmission in the Greater Accra Region of Ghana.

Authors:  Kofi Dadzie Kwofie; Anita Ghansah; Joseph Harold Nyarko Osei; Kwadwo Kyereme Frempong; Samuel Obed; Eric H Frimpong; Daniel A Boakye; Takashi Suzuki; Nobuo Ohta; Irene Ayi
Journal:  Matern Child Health J       Date:  2016-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.